English
简体中文
Total: £ 56.28
Published Date: 2026-04-01 | Pages: 136 | Tables: 140 | Chemical & Material
The global Methotrexate API market was valued at US$ 36.10 million in 2025 and is anticipated to reach US$ 46.05 million by 2032, at a CAGR of 3.3% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Methotrexate API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Methotrexate is an antimetabolite and folate antagonist that inhibits the activity of dihydrofolate reductase (DHFR), thereby disrupting DNA and RNA synthesis. It is widely used in oncology and in the treatment of autoimmune diseases.
In 2025, the global production of methotrexate APIs was 9.5 tons, with an average price of US$3,800 per kilogram.
Upstream includes suppliers of basic chemical raw materials such as para-aminobenzoic acid derivatives and other intermediates, providers of organic synthesis reagents and solvents, fine chemical intermediate manufacturers and pharmaceutical equipment and process technology suppliers. Chemical intermediates and synthesis processes account for a significant portion of cost, followed by quality control and environmental compliance expenses. The multi-step synthesis process requires strict control over process stability and impurity profiles.
Downstream applications include the production of anticancer drugs, anti-rheumatic medications and immunosuppressive therapies. In oncology, methotrexate is used to treat leukemia, lymphoma and certain solid tumors. In autoimmune disease treatment, it is widely used for conditions such as rheumatoid arthritis and psoriasis. Demand is closely related to cancer incidence rates, the prevalence of autoimmune diseases and the expansion of the global generic drug market, where it remains a widely used essential medicine.
Industry trends focus on optimizing high-purity synthesis processes, adopting green chemistry methods, implementing continuous manufacturing technologies and improving impurity control and quality standards. With increasingly stringent regulatory requirements, API manufacturers must comply with international standards such as GMP, raising expectations for process control, environmental management and product consistency. Cost efficiency and large-scale production capabilities are also key competitive factors.
Gross margins typically range from 20% to 40%. Standard generic APIs generally achieve margins of approximately 20%–30%, while high-purity, high-quality or internationally certified products may reach 30%–40%. Key industry barriers include synthesis process control, quality management systems and regulatory compliance capabilities. Market demand is closely linked to pharmaceutical market growth, cancer and autoimmune disease treatment needs and the expansion of the global generics industry.
This report delivers a comprehensive overview of the global Methotrexate API market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Methotrexate API. The Methotrexate API market size, estimates, and forecasts are provided in terms of output/shipments (kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Methotrexate API market comprehensively. Regional market sizes by Purity, by Application, by Process, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Methotrexate API manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Purity, by Application, and by region.
Market Segmentation
By Company
Zhejiang Hisun
Alembic
Shilpa
Fermion
Excella
Farmhispania
Fujian South Pharmaceutical
Sichuan Huiyu Pharmaceutical
Sichuan Elixir Pharmaceuticals
Huzhou Zhanwang Pharmaceutical
Sakar Healthcare
CF Pharma
Segment by Purity
Below 98%
Above 98%
Segment by Process
Chemically Synthesized
Process-Optimized
Segment by Function
Oncology Treatment
Autoimmune Disease Therapy
Anti-Inflammatory And Immunomodulatory Therapy
by Application
Clinical Treatment
Experimental Research
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Egypt
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Purity, by Application, by Process, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Methotrexate API manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Methotrexate API production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Methotrexate API consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Purity, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Methotrexate API Market Overview
1.1 Product Definition
1.2 Methotrexate API by Purity
1.2.1 Global Methotrexate API Market Value Growth Rate Analysis by Purity: 2025 vs 2032
1.2.2 Below 98%
1.2.3 Above 98%
1.3 Methotrexate API by Process
1.3.1 Global Methotrexate API Market Value Growth Rate Analysis by Process: 2025 vs 2032
1.3.2 Chemically Synthesized
1.3.3 Process-Optimized
1.4 Methotrexate API by Function
1.4.1 Global Methotrexate API Market Value Growth Rate Analysis by Function: 2025 vs 2032
1.4.2 Oncology Treatment
1.4.3 Autoimmune Disease Therapy
1.4.4 Anti-Inflammatory And Immunomodulatory Therapy
1.5 Methotrexate API by Application
1.5.1 Global Methotrexate API Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.5.2 Clinical Treatment
1.5.3 Experimental Research
1.6 Global Market Growth Prospects
1.6.1 Global Methotrexate API Production Value Estimates and Forecasts (2021–2032)
1.6.2 Global Methotrexate API Production Capacity Estimates and Forecasts (2021–2032)
1.6.3 Global Methotrexate API Production Estimates and Forecasts (2021–2032)
1.6.4 Global Methotrexate API Market Average Price Estimates and Forecasts (2021–2032)
1.7 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Methotrexate API Production Market Share by Manufacturers (2021–2026)
2.2 Global Methotrexate API Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Methotrexate API, Industry Ranking, 2024 vs 2025
2.4 Global Methotrexate API Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Methotrexate API Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Methotrexate API, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Methotrexate API, Product Offerings and Applications
2.8 Global Key Manufacturers of Methotrexate API, Date of Entry into the Industry
2.9 Methotrexate API Market Competitive Situation and Trends
2.9.1 Methotrexate API Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Methotrexate API Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Methotrexate API Production by Region
3.1 Global Methotrexate API Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Methotrexate API Production Value by Region (2021–2032)
3.2.1 Global Methotrexate API Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Methotrexate API by Region (2027–2032)
3.3 Global Methotrexate API Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Methotrexate API Production Volume by Region (2021–2032)
3.4.1 Global Methotrexate API Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Methotrexate API by Region (2027–2032)
3.5 Global Methotrexate API Market Price Analysis by Region (2021–2032)
3.6 Global Methotrexate API Production, Value, and Year-over-Year Growth
3.6.1 North America Methotrexate API Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Methotrexate API Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Methotrexate API Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Methotrexate API Production Value Estimates and Forecasts (2021–2032)
4 Methotrexate API Consumption by Region
4.1 Global Methotrexate API Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Methotrexate API Consumption by Region (2021–2032)
4.2.1 Global Methotrexate API Consumption by Region (2021–2026)
4.2.2 Global Methotrexate API Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Methotrexate API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Methotrexate API Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Methotrexate API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Methotrexate API Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Methotrexate API Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Methotrexate API Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Methotrexate API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Methotrexate API Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Purity
5.1 Global Methotrexate API Production by Purity (2021–2032)
5.1.1 Global Methotrexate API Production by Purity (2021–2026)
5.1.2 Global Methotrexate API Production by Purity (2027–2032)
5.1.3 Global Methotrexate API Production Market Share by Purity (2021–2032)
5.2 Global Methotrexate API Production Value by Purity (2021–2032)
5.2.1 Global Methotrexate API Production Value by Purity (2021–2026)
5.2.2 Global Methotrexate API Production Value by Purity (2027–2032)
5.2.3 Global Methotrexate API Production Value Market Share by Purity (2021–2032)
5.3 Global Methotrexate API Price by Purity (2021–2032)
6 Segment by Application
6.1 Global Methotrexate API Production by Application (2021–2032)
6.1.1 Global Methotrexate API Production by Application (2021–2026)
6.1.2 Global Methotrexate API Production by Application (2027–2032)
6.1.3 Global Methotrexate API Production Market Share by Application (2021–2032)
6.2 Global Methotrexate API Production Value by Application (2021–2032)
6.2.1 Global Methotrexate API Production Value by Application (2021–2026)
6.2.2 Global Methotrexate API Production Value by Application (2027–2032)
6.2.3 Global Methotrexate API Production Value Market Share by Application (2021–2032)
6.3 Global Methotrexate API Price by Application (2021–2032)
7 Key Companies Profiled
7.1 Zhejiang Hisun
7.1.1 Zhejiang Hisun Methotrexate API Company Information
7.1.2 Zhejiang Hisun Methotrexate API Product Portfolio
7.1.3 Zhejiang Hisun Methotrexate API Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 Zhejiang Hisun Main Business and Markets Served
7.1.5 Zhejiang Hisun Recent Developments/Updates
7.2 Alembic
7.2.1 Alembic Methotrexate API Company Information
7.2.2 Alembic Methotrexate API Product Portfolio
7.2.3 Alembic Methotrexate API Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 Alembic Main Business and Markets Served
7.2.5 Alembic Recent Developments/Updates
7.3 Shilpa
7.3.1 Shilpa Methotrexate API Company Information
7.3.2 Shilpa Methotrexate API Product Portfolio
7.3.3 Shilpa Methotrexate API Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Shilpa Main Business and Markets Served
7.3.5 Shilpa Recent Developments/Updates
7.4 Fermion
7.4.1 Fermion Methotrexate API Company Information
7.4.2 Fermion Methotrexate API Product Portfolio
7.4.3 Fermion Methotrexate API Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Fermion Main Business and Markets Served
7.4.5 Fermion Recent Developments/Updates
7.5 Excella
7.5.1 Excella Methotrexate API Company Information
7.5.2 Excella Methotrexate API Product Portfolio
7.5.3 Excella Methotrexate API Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Excella Main Business and Markets Served
7.5.5 Excella Recent Developments/Updates
7.6 Farmhispania
7.6.1 Farmhispania Methotrexate API Company Information
7.6.2 Farmhispania Methotrexate API Product Portfolio
7.6.3 Farmhispania Methotrexate API Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Farmhispania Main Business and Markets Served
7.6.5 Farmhispania Recent Developments/Updates
7.7 Fujian South Pharmaceutical
7.7.1 Fujian South Pharmaceutical Methotrexate API Company Information
7.7.2 Fujian South Pharmaceutical Methotrexate API Product Portfolio
7.7.3 Fujian South Pharmaceutical Methotrexate API Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 Fujian South Pharmaceutical Main Business and Markets Served
7.7.5 Fujian South Pharmaceutical Recent Developments/Updates
7.8 Sichuan Huiyu Pharmaceutical
7.8.1 Sichuan Huiyu Pharmaceutical Methotrexate API Company Information
7.8.2 Sichuan Huiyu Pharmaceutical Methotrexate API Product Portfolio
7.8.3 Sichuan Huiyu Pharmaceutical Methotrexate API Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 Sichuan Huiyu Pharmaceutical Main Business and Markets Served
7.8.5 Sichuan Huiyu Pharmaceutical Recent Developments/Updates
7.9 Sichuan Elixir Pharmaceuticals
7.9.1 Sichuan Elixir Pharmaceuticals Methotrexate API Company Information
7.9.2 Sichuan Elixir Pharmaceuticals Methotrexate API Product Portfolio
7.9.3 Sichuan Elixir Pharmaceuticals Methotrexate API Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 Sichuan Elixir Pharmaceuticals Main Business and Markets Served
7.9.5 Sichuan Elixir Pharmaceuticals Recent Developments/Updates
7.10 Huzhou Zhanwang Pharmaceutical
7.10.1 Huzhou Zhanwang Pharmaceutical Methotrexate API Company Information
7.10.2 Huzhou Zhanwang Pharmaceutical Methotrexate API Product Portfolio
7.10.3 Huzhou Zhanwang Pharmaceutical Methotrexate API Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 Huzhou Zhanwang Pharmaceutical Main Business and Markets Served
7.10.5 Huzhou Zhanwang Pharmaceutical Recent Developments/Updates
7.11 Sakar Healthcare
7.11.1 Sakar Healthcare Methotrexate API Company Information
7.11.2 Sakar Healthcare Methotrexate API Product Portfolio
7.11.3 Sakar Healthcare Methotrexate API Production, Value, Price, and Gross Margin (2021–2026)
7.11.4 Sakar Healthcare Main Business and Markets Served
7.11.5 Sakar Healthcare Recent Developments/Updates
7.12 CF Pharma
7.12.1 CF Pharma Methotrexate API Company Information
7.12.2 CF Pharma Methotrexate API Product Portfolio
7.12.3 CF Pharma Methotrexate API Production, Value, Price, and Gross Margin (2021–2026)
7.12.4 CF Pharma Main Business and Markets Served
7.12.5 CF Pharma Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Methotrexate API Industry Chain Analysis
8.2 Methotrexate API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Methotrexate API Production Modes and Processes
8.4 Methotrexate API Sales and Marketing
8.4.1 Methotrexate API Sales Channels
8.4.2 Methotrexate API Distributors
8.5 Methotrexate API Customer Analysis
9 Methotrexate API Market Dynamics
9.1 Methotrexate API Industry Trends
9.2 Methotrexate API Market Drivers
9.3 Methotrexate API Market Challenges
9.4 Methotrexate API Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
Table 1. Global Methotrexate API Market Value by Purity (US$ Million), 2025 vs 2032
Table 2. Global Methotrexate API Market Value by Process (US$ Million), 2025 vs 2032
Table 3. Global Methotrexate API Market Value by Function (US$ Million), 2025 vs 2032
Table 4. Global Methotrexate API Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Methotrexate API Production Capacity (kg) by Manufacturers in 2025
Table 6. Global Methotrexate API Production by Manufacturers (kg), 2021–2026
Table 7. Global Methotrexate API Production Market Share by Manufacturers (2021–2026)
Table 8. Global Methotrexate API Production Value by Manufacturers (US$ Million), 2021–2026
Table 9. Global Methotrexate API Production Value Share by Manufacturers (2021–2026)
Table 10. Global Key Players of Methotrexate API, Industry Ranking, 2024 vs 2025
Table 11. Classification of Companies by Tier (Tier 1, Tier 2, Tier 3), based on Methotrexate API Production Value, 2025
Table 12. Global Market Methotrexate API Average Price by Manufacturers (US$/kg), 2021–2026
Table 13. Global Key Manufacturers of Methotrexate API, Manufacturing Footprints and Headquarters
Table 14. Global Key Manufacturers of Methotrexate API, Product Offerings and Applications
Table 15. Global Key Manufacturers of Methotrexate API, Date of Entry into the Industry
Table 16. Global Methotrexate API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Mergers & Acquisitions and Expansion Plans
Table 18. Global Methotrexate API Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 19. Global Methotrexate API Production Value (US$ Million) by Region (2021–2026)
Table 20. Global Methotrexate API Production Value Market Share by Region (2021–2026)
Table 21. Global Methotrexate API Production Value (US$ Million) Forecast by Region (2027–2032)
Table 22. Global Methotrexate API Production Value Market Share Forecast by Region (2027–2032)
Table 23. Global Methotrexate API Production Comparison by Region: 2021 vs 2025 vs 2032 (kg)
Table 24. Global Methotrexate API Production (kg) by Region (2021–2026)
Table 25. Global Methotrexate API Production Market Share by Region (2021–2026)
Table 26. Global Methotrexate API Production (kg) Forecast by Region (2027–2032)
Table 27. Global Methotrexate API Production Market Share Forecast by Region (2027–2032)
Table 28. Global Methotrexate API Market Average Price (US$/kg) by Region (2021–2026)
Table 29. Global Methotrexate API Market Average Price (US$/kg) by Region (2027–2032)
Table 30. Global Methotrexate API Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (kg)
Table 31. Global Methotrexate API Consumption by Region (kg), 2021–2026
Table 32. Global Methotrexate API Consumption Market Share by Region (2021–2026)
Table 33. Global Methotrexate API Forecasted Consumption by Region (kg), 2027–2032
Table 34. Global Methotrexate API Forecasted Consumption Market Share by Region (2027–2032)
Table 35. North America Methotrexate API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (kg)
Table 36. North America Methotrexate API Consumption by Country (kg), 2021–2026
Table 37. North America Methotrexate API Consumption by Country (kg), 2027–2032
Table 38. Europe Methotrexate API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (kg)
Table 39. Europe Methotrexate API Consumption by Country (kg), 2021–2026
Table 40. Europe Methotrexate API Consumption by Country (kg), 2027–2032
Table 41. Asia Pacific Methotrexate API Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (kg)
Table 42. Asia Pacific Methotrexate API Consumption by Region (kg), 2021–2026
Table 43. Asia Pacific Methotrexate API Consumption by Region (kg), 2027–2032
Table 44. Latin America, Middle East & Africa Methotrexate API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (kg)
Table 45. Latin America, Middle East & Africa Methotrexate API Consumption by Country (kg), 2021–2026
Table 46. Latin America, Middle East & Africa Methotrexate API Consumption by Country (kg), 2027–2032
Table 47. Global Methotrexate API Production (kg) by Purity (2021–2026)
Table 48. Global Methotrexate API Production (kg) by Purity (2027–2032)
Table 49. Global Methotrexate API Production Market Share by Purity (2021–2026)
Table 50. Global Methotrexate API Production Market Share by Purity (2027–2032)
Table 51. Global Methotrexate API Production Value (US$ Million) by Purity (2021–2026)
Table 52. Global Methotrexate API Production Value (US$ Million) by Purity (2027–2032)
Table 53. Global Methotrexate API Production Value Market Share by Purity (2021–2026)
Table 54. Global Methotrexate API Production Value Market Share by Purity (2027–2032)
Table 55. Global Methotrexate API Price (US$/kg) by Purity (2021–2026)
Table 56. Global Methotrexate API Price (US$/kg) by Purity (2027–2032)
Table 57. Global Methotrexate API Production (kg) by Application (2021–2026)
Table 58. Global Methotrexate API Production (kg) by Application (2027–2032)
Table 59. Global Methotrexate API Production Market Share by Application (2021–2026)
Table 60. Global Methotrexate API Production Market Share by Application (2027–2032)
Table 61. Global Methotrexate API Production Value (US$ Million) by Application (2021–2026)
Table 62. Global Methotrexate API Production Value (US$ Million) by Application (2027–2032)
Table 63. Global Methotrexate API Production Value Market Share by Application (2021–2026)
Table 64. Global Methotrexate API Production Value Market Share by Application (2027–2032)
Table 65. Global Methotrexate API Price (US$/kg) by Application (2021–2026)
Table 66. Global Methotrexate API Price (US$/kg) by Application (2027–2032)
Table 67. Zhejiang Hisun Methotrexate API Company Information
Table 68. Zhejiang Hisun Methotrexate API Specification and Application
Table 69. Zhejiang Hisun Methotrexate API Production (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 70. Zhejiang Hisun Main Business and Markets Served
Table 71. Zhejiang Hisun Recent Developments/Updates
Table 72. Alembic Methotrexate API Company Information
Table 73. Alembic Methotrexate API Specification and Application
Table 74. Alembic Methotrexate API Production (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 75. Alembic Main Business and Markets Served
Table 76. Alembic Recent Developments/Updates
Table 77. Shilpa Methotrexate API Company Information
Table 78. Shilpa Methotrexate API Specification and Application
Table 79. Shilpa Methotrexate API Production (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 80. Shilpa Main Business and Markets Served
Table 81. Shilpa Recent Developments/Updates
Table 82. Fermion Methotrexate API Company Information
Table 83. Fermion Methotrexate API Specification and Application
Table 84. Fermion Methotrexate API Production (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 85. Fermion Main Business and Markets Served
Table 86. Fermion Recent Developments/Updates
Table 87. Excella Methotrexate API Company Information
Table 88. Excella Methotrexate API Specification and Application
Table 89. Excella Methotrexate API Production (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 90. Excella Main Business and Markets Served
Table 91. Excella Recent Developments/Updates
Table 92. Farmhispania Methotrexate API Company Information
Table 93. Farmhispania Methotrexate API Specification and Application
Table 94. Farmhispania Methotrexate API Production (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 95. Farmhispania Main Business and Markets Served
Table 96. Farmhispania Recent Developments/Updates
Table 97. Fujian South Pharmaceutical Methotrexate API Company Information
Table 98. Fujian South Pharmaceutical Methotrexate API Specification and Application
Table 99. Fujian South Pharmaceutical Methotrexate API Production (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 100. Fujian South Pharmaceutical Main Business and Markets Served
Table 101. Fujian South Pharmaceutical Recent Developments/Updates
Table 102. Sichuan Huiyu Pharmaceutical Methotrexate API Company Information
Table 103. Sichuan Huiyu Pharmaceutical Methotrexate API Specification and Application
Table 104. Sichuan Huiyu Pharmaceutical Methotrexate API Production (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 105. Sichuan Huiyu Pharmaceutical Main Business and Markets Served
Table 106. Sichuan Huiyu Pharmaceutical Recent Developments/Updates
Table 107. Sichuan Elixir Pharmaceuticals Methotrexate API Company Information
Table 108. Sichuan Elixir Pharmaceuticals Methotrexate API Specification and Application
Table 109. Sichuan Elixir Pharmaceuticals Methotrexate API Production (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 110. Sichuan Elixir Pharmaceuticals Main Business and Markets Served
Table 111. Sichuan Elixir Pharmaceuticals Recent Developments/Updates
Table 112. Huzhou Zhanwang Pharmaceutical Methotrexate API Company Information
Table 113. Huzhou Zhanwang Pharmaceutical Methotrexate API Specification and Application
Table 114. Huzhou Zhanwang Pharmaceutical Methotrexate API Production (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 115. Huzhou Zhanwang Pharmaceutical Main Business and Markets Served
Table 116. Huzhou Zhanwang Pharmaceutical Recent Developments/Updates
Table 117. Sakar Healthcare Methotrexate API Company Information
Table 118. Sakar Healthcare Methotrexate API Specification and Application
Table 119. Sakar Healthcare Methotrexate API Production (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 120. Sakar Healthcare Main Business and Markets Served
Table 121. Sakar Healthcare Recent Developments/Updates
Table 122. CF Pharma Methotrexate API Company Information
Table 123. CF Pharma Methotrexate API Specification and Application
Table 124. CF Pharma Methotrexate API Production (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 125. CF Pharma Main Business and Markets Served
Table 126. CF Pharma Recent Developments/Updates
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Methotrexate API Distributors List
Table 130. Methotrexate API Customers List
Table 131. Methotrexate API Market Trends
Table 132. Methotrexate API Market Drivers
Table 133. Methotrexate API Market Challenges
Table 134. Methotrexate API Market Restraints
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
Table 138. Authors List of This Report
List of Figures
Figure 1. Product Picture of Methotrexate API
Figure 2. Global Methotrexate API Market Value by Purity (US$ Million), 2021–2032
Figure 3. Global Methotrexate API Market Share by Purity: 2025 vs 2032
Figure 4. Below 98% Product Picture
Figure 5. Above 98% Product Picture
Figure 6. Global Methotrexate API Market Value by Process (US$ Million), 2021–2032
Figure 7. Global Methotrexate API Market Share by Process: 2025 vs 2032
Figure 8. Chemically Synthesized Product Picture
Figure 9. Process-Optimized Product Picture
Figure 10. Global Methotrexate API Market Value by Function (US$ Million), 2021–2032
Figure 11. Global Methotrexate API Market Share by Function: 2025 vs 2032
Figure 12. Oncology Treatment Product Picture
Figure 13. Autoimmune Disease Therapy Product Picture
Figure 14. Anti-Inflammatory And Immunomodulatory Therapy Product Picture
Figure 15. Global Methotrexate API Market Value by Application (US$ Million), 2021–2032
Figure 16. Global Methotrexate API Market Share by Application: 2025 vs 2032
Figure 17. Clinical Treatment
Figure 18. Experimental Research
Figure 19. Global Methotrexate API Production Value (US$ Million), 2021 vs 2025 vs 2032
Figure 20. Global Methotrexate API Production Value (US$ Million), 2021–2032
Figure 21. Global Methotrexate API Production Capacity (kg), 2021–2032
Figure 22. Global Methotrexate API Production (kg), 2021–2032
Figure 23. Global Methotrexate API Average Price (US$/kg), 2021–2032
Figure 24. Methotrexate API Report Years Considered
Figure 25. Methotrexate API Production Share by Manufacturers in 2025
Figure 26. Global Methotrexate API Production Value Share by Manufacturers (2025)
Figure 27. Methotrexate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 28. Top 5 and Top 10 Global Players: Market Share by Methotrexate API Revenue in 2025
Figure 29. Global Methotrexate API Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 30. Global Methotrexate API Production Value Market Share by Region: 2021 vs 2025 vs 2032
Figure 31. Global Methotrexate API Production Comparison by Region: 2021 vs 2025 vs 2032 (kg)
Figure 32. Global Methotrexate API Production Market Share by Region: 2021 vs 2025 vs 2032
Figure 33. North America Methotrexate API Production Value (US$ Million) Growth Rate (2021–2032)
Figure 34. Europe Methotrexate API Production Value (US$ Million) Growth Rate (2021–2032)
Figure 35. China Methotrexate API Production Value (US$ Million) Growth Rate (2021–2032)
Figure 36. Japan Methotrexate API Production Value (US$ Million) Growth Rate (2021–2032)
Figure 37. Global Methotrexate API Consumption by Region: 2021 vs 2025 vs 2032 (kg)
Figure 38. Global Methotrexate API Consumption Market Share by Region: 2021 vs 2025 vs 2032
Figure 39. North America Methotrexate API Consumption and Growth Rate (kg), 2021–2032
Figure 40. North America Methotrexate API Consumption Market Share by Country (2021–2032)
Figure 41. U.S. Methotrexate API Consumption and Growth Rate (kg), 2021–2032
Figure 42. Canada Methotrexate API Consumption and Growth Rate (kg), 2021–2032
Figure 43. Europe Methotrexate API Consumption and Growth Rate (kg), 2021–2032
Figure 44. Europe Methotrexate API Consumption Market Share by Country (2021–2032)
Figure 45. Germany Methotrexate API Consumption and Growth Rate (kg), 2021–2032
Figure 46. France Methotrexate API Consumption and Growth Rate (kg), 2021–2032
Figure 47. U.K. Methotrexate API Consumption and Growth Rate (kg), 2021–2032
Figure 48. Italy Methotrexate API Consumption and Growth Rate (kg), 2021–2032
Figure 49. Russia Methotrexate API Consumption and Growth Rate (kg), 2021–2032
Figure 50. Asia Pacific Methotrexate API Consumption and Growth Rate (kg), 2021–2032
Figure 51. Asia Pacific Methotrexate API Consumption Market Share by Region (2021–2032)
Figure 52. China Methotrexate API Consumption and Growth Rate (kg), 2021–2032
Figure 53. Japan Methotrexate API Consumption and Growth Rate (kg), 2021–2032
Figure 54. South Korea Methotrexate API Consumption and Growth Rate (kg), 2021–2032
Figure 55. China Taiwan Methotrexate API Consumption and Growth Rate (kg), 2021–2032
Figure 56. Southeast Asia Methotrexate API Consumption and Growth Rate (kg), 2021–2032
Figure 57. India Methotrexate API Consumption and Growth Rate (kg), 2021–2032
Figure 58. Latin America, Middle East & Africa Methotrexate API Consumption and Growth Rate (kg), 2021–2032
Figure 59. Latin America, Middle East & Africa Methotrexate API Consumption Market Share by Country (2021–2032)
Figure 60. Mexico Methotrexate API Consumption and Growth Rate (kg), 2021–2032
Figure 61. Brazil Methotrexate API Consumption and Growth Rate (kg), 2021–2032
Figure 62. Turkey Methotrexate API Consumption and Growth Rate (kg), 2021–2032
Figure 63. GCC Countries Methotrexate API Consumption and Growth Rate (kg), 2021–2032
Figure 64. Global Production Market Share of Methotrexate API by Purity (2021–2032)
Figure 65. Global Production Value Market Share of Methotrexate API by Purity (2021–2032)
Figure 66. Global Methotrexate API Price (US$/kg) by Purity (2021–2032)
Figure 67. Global Production Market Share of Methotrexate API by Application (2021–2032)
Figure 68. Global Production Value Market Share of Methotrexate API by Application (2021–2032)
Figure 69. Global Methotrexate API Price (US$/kg) by Application (2021–2032)
Figure 70. Methotrexate API Value Chain
Figure 71. Channels of Distribution (Direct Vs Distribution)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
